An 8 week study providing 2.4 g fish oil per day (with an EPA:DHA of 2:1) to HD patients with metabolic syndrome found reductions in CRP, TNF-alpha and IL-6 levels; however, the lack of placebo control should be noted [153]. The gene discussed is CRP; the disease is Huntington disease.